<ol class="cite-this-references"><li id="reference-A176035">Pacifici GM: Metabolism and pharmacokinetics of morphine in neonates: A review. Clinics (Sao Paulo). 2016 Aug;71(8):474-80. doi: 10.6061/clinics/2016(08)11. [<a href="/articles/A176035" target="_blank">Article</a>] </li><li id="reference-A176050">Kim J, Ham S, Hong H, Moon C, Im HI: Brain Reward Circuits in Morphine Addiction. Mol Cells. 2016 Sep;39(9):645-53. doi: 10.14348/molcells.2016.0137. Epub 2016 Aug 9. [<a href="/articles/A176050" target="_blank">Article</a>] </li><li id="reference-A176056">Beltran-Campos V, Silva-Vera M, Garcia-Campos ML, Diaz-Cintra S: Effects of morphine on brain plasticity. Neurologia. 2015 Apr;30(3):176-80. doi: 10.1016/j.nrl.2014.08.004. Epub 2014 Nov 11. [<a href="/articles/A176056" target="_blank">Article</a>] </li><li id="reference-A176059">Klimas R, Mikus G: Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide. Br J Anaesth. 2014 Dec;113(6):935-44. doi: 10.1093/bja/aeu186. Epub 2014 Jul 1. [<a href="/articles/A176059" target="_blank">Article</a>] </li><li id="reference-A176116">Lotsch J: Pharmacokinetic-pharmacodynamic modeling of opioids. J Pain Symptom Manage. 2005 May;29(5 Suppl):S90-103. doi: 10.1016/j.jpainsymman.2005.01.012. [<a href="/articles/A176116" target="_blank">Article</a>] </li><li id="reference-A176119">Hoskin PJ, Hanks GW: Morphine: pharmacokinetics and clinical practice. Br J Cancer. 1990 Nov;62(5):705-7. [<a href="/articles/A176119" target="_blank">Article</a>] </li><li id="reference-A176122">Glare PA, Walsh TD: Clinical pharmacokinetics of morphine. Ther Drug Monit. 1991 Jan;13(1):1-23. [<a href="/articles/A176122" target="_blank">Article</a>] </li><li id="reference-A176164">Stuart-Harris R, Joel SP, McDonald P, Currow D, Slevin ML: The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine. Br J Clin Pharmacol. 2000 Mar;49(3):207-14. [<a href="/articles/A176164" target="_blank">Article</a>] </li><li id="reference-A176167">Shigeev S: Severity of opiate intoxication to gender and age. Soud Lek. 2007 Jan;52(1):21-4. [<a href="/articles/A176167" target="_blank">Article</a>] </li><li id="reference-L5713">FDA approvals [<a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&amp;ApplNo=018565" target="_blank">Link</a>] </li><li id="reference-L5728">NIH [<a href="https://medlineplus.gov/magazine/issues/spring11/articles/spring11pg9.html" target="_blank">Link</a>] </li><li id="reference-L12108">FDA Approved Drug Products: Infumorph Morphine Sulfate Injection [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018565s024lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L12114">FDA Approved Drug Products: Morphine Sulfate Oral Tablets [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022207s009lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L35490">FDA Approved Drug Products: Morphine Sulfate Oral Solution [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022195s020lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L35495">FDA Approved Drug Products: MS Contin (Morphine Sulfate) Oral Extended Release Tablet [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019516s057lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L35500">FDA Approved Drug Products: Kadian (Morphine Sulfate) Oral Extended Release Capsules [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020616s065lbl.pdf" target="_blank">Link</a>] </li></ol>